This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Despite clear benefits, AI diagnostics face high licensing hurdles in US

By Melissa Ritti ( February 10, 2026, 18:39 GMT | Insight) -- Modern medicine has been transformed by artificial intelligence, particularly in the field of diagnostics. Such breakthroughs are doubly disadvantaged when it comes to patent prosecution and enforcement in the US, however, in an ongoing challenge for technology transfer officials.Artificial intelligence is being successfully harnessed to improve patient outcomes, spotting disease and degenerative disorders earlier than ever before....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login